SCHEMBL19081942

SCHEMBL19081942

c1cc(-c2ccc3oc4c(ccc5c6ccc7ccccc7c6sc54)c3c2)cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.37
CYP1B1 Q16678 5/20 0.37
CYP1A2 P05177 3/20 0.34
ALOX5 P09917 1/20 0.34
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
PLA2G10 O15496 1/20 0.33
PLA2G2A P14555 1/20 0.33
PLA2G4A P47712 1/20 0.33
PIM1 P11309 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081982 0.91 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2KMT2AMAPK1
SCHEMBL22680682 0.91 ALOX5 (0.41) CYP1A2ALOX5KMT2AKDM4EMAPT
SCHEMBL19081943 0.89 CYP1A1 (0.35) CYP1A1CYP1B1CYP1A2ALOX5KMT2A
SCHEMBL16067815 0.88 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ALOX5MAPK1
SCHEMBL22868287 0.87 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ALOX5MAPK1
SCHEMBL19080277 0.86 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2ALOX5MAPK1
SCHEMBL19081551 0.85 PLA2G2A (0.38) CYP1A1CYP1B1CYP1A2ALOX5KMT2A
SCHEMBL10122426 0.85 ALOX5 (0.44) CYP1A2ALOX5KMT2AMAPK1KDM4E
SCHEMBL19081775 0.85 ALOX5 (0.34) CYP1A1CYP1A2ALOX5KMT2AMAPK1
SCHEMBL19091018 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.